Report Categories
View AllRecent Articles
View All
Regeneron Pharmaceuticals Inc REGN Bullish Analyst Ratings Underscore Oncology Pipeline Upside and Core Product Resilience
RADX Radiopharm outlines strategic priority for latestage theranostic pipeline expansion to drive longterm revenue growth
ARCIU Arc SPAC III management prioritizes highgrowth AI startup targets in its latest quarterly earnings filing
What tail risk New NMFCZ Neutral 20260427
Regeneron Pharmaceuticals Inc REGN Bullish Analyst Ratings Underscore Oncology Pipeline Upside and Core Product Resilience
PDSB PDS shares drop 11 percent despite Q4 2025 per share loss coming in narrower than analyst estimates
What Legend LEGN subscription metrics reveal about retention Q4 2025 Profit Disappoints
What INNEOVA INEO disclosed about legal liabilities
WNEB beats Q1 estimates by 12 on strong 136 revenue growth yet shares slip despite earnings beat
The key driver behind BriaCell BCTXZ revenue growth
BYRN Byrna posts 697 percent Q1 2026 EPS miss shares dip 171 percent on soft investor sentiment
What TenLeague TLIH does that creates lasting value Trend Weakens 20260508
RUSHB Rush Enterprises tops Q1 2026 EPS estimates by 79 percent shares rise modestly today